Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) EBIT Margin (2020 - 2026)

PROCEPT BioRobotics has reported EBIT Margin over the past 7 years, most recently at 39.22% for Q1 2026.

  • Quarterly EBIT Margin rose 45.0% to 39.22% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 33.86% through Mar 2026, up 484.0% year-over-year, with the annual reading at 33.71% for FY2025, 932.0% up from the prior year.
  • EBIT Margin was 39.22% for Q1 2026 at PROCEPT BioRobotics, up from 40.64% in the prior quarter.
  • Over five years, EBIT Margin peaked at 27.83% in Q3 2025 and troughed at 116.28% in Q1 2023.
  • The 5-year median for EBIT Margin is 62.08% (2024), against an average of 65.95%.
  • Year-over-year, EBIT Margin soared 6071bps in 2022 and then plummeted -1175bps in 2025.
  • A 5-year view of EBIT Margin shows it stood at 105.31% in 2022, then surged by 36bps to 67.82% in 2023, then soared by 57bps to 28.89% in 2024, then plummeted by -41bps to 40.64% in 2025, then grew by 3bps to 39.22% in 2026.
  • Per Business Quant, the three most recent readings for PRCT's EBIT Margin are 39.22% (Q1 2026), 40.64% (Q4 2025), and 27.83% (Q3 2025).